Valpalf®: A New Nutraceutical Formulation Containing Bovine Lactoferrin That Exhibits Potentiated Biological Activity
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168559 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Luigi Rosa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Lactoferrin, Dietary Supplements, Superoxide Dismutase, Interleukin-6. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As a nutraceutical, bovine lactoferrin (bLf), an iron-binding glycoprotein involved in innate immunity, is gaining elevated attention for its ability to exert pleiotropic functions and to be exceptionally tolerated even at high dosages. Some of bLf’s activities, including its anti-inflammatory and antioxidant, are tightly linked to its ability to both chelate iron and enter inside the cell nucleus. Here, we present data about Valpalf®, a new formulation containing bLf, sodium citrate, and sodium bicarbonate at a molar ratio of 10−3. In the present study, Valpalf® exhibits superior iron-binding capacity, resistance to tryptic digestion, and a greater capacity to accumulate into the nucleus over time when compared to the native bLf alone. In agreement, Valpalf® effectively reduces interleukin(IL)-6 levels in lipopolysaccharide-stimulated macrophages and modulates the expression of antioxidant enzymes, such as superoxide dismutase 1 and 2, in phorbol-12-myristate-13-acetate-stimulated monocytes. Of note, this potentiated bioactivity was corroborated in a retrospective study on the treatment of anemia of inflammation in hereditary thrombophilic pregnant and non-pregnant women, demonstrating that Valpalf® improves hematological parameters and reduces serum IL-6 levels to a higher extent than bLf alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
- Department of Biosciences and Territory, University of Molise, 86090 Pesche, Italy.
- Microbo s.r.l., 00153 Rome, Italy.
ORCID-Profile: Luigi Rosa, Giusi Ianiro, Giovanni Musci, Antimo Cutone
Zitieren
APA
Rosa, L., Ianiro, G., Niro, A., Musci, G., Paesano, R., Cutone, A., & Valenti, P. (2024). Valpalf®: A New Nutraceutical Formulation Containing Bovine Lactoferrin That Exhibits Potentiated Biological Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168559
Vancouver
Rosa L, Ianiro G, Niro A, Musci G, Paesano R, Cutone A, et al. Valpalf®: A New Nutraceutical Formulation Containing Bovine Lactoferrin That Exhibits Potentiated Biological Activity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168559
BibTeX
@article{Rosa2024,
author = {Rosa, Luigi and Ianiro, Giusi and Niro, Antonella and Musci, Giovanni and Paesano, Rosalba and Cutone, Antimo and Valenti, Piera},
title = {Valpalf®: A New Nutraceutical Formulation Containing Bovine Lactoferrin That Exhibits Potentiated Biological Activity},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168559}
}
EUVIMED